Patents by Inventor Jean-Marc Schlaeppi

Jean-Marc Schlaeppi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050176062
    Abstract: The present invention provides a method of identifying a ligand to a nuclear receptor protein comprising wherein said nuclear receptor protein is first expressed in an eukaryotic expression system in the presence of at least one candidate ligand. The nuclear receptor protein is then purified, isolated and mass spectrometry is used to determine the presence of a bound ligand. The ligand is finally isolated and the measured spectra is compared with the spectra of known ligands in compound libraries to identify the ligand.
    Type: Application
    Filed: April 28, 2003
    Publication date: August 11, 2005
    Inventors: Reiner Aichholz, Francis Bitsch, Sabine Geisse, Jean-Marc Schlaeppi
  • Publication number: 20050165218
    Abstract: The present invention relates RORa in crystallized form and methods for the preparation thereof. The invention also provides a three-dimensional model of RORa and means for the design of RORa modulators. Ligands binding to RORa are also provided.
    Type: Application
    Filed: April 28, 2003
    Publication date: July 28, 2005
    Inventors: Rene Beerli, Brigitte Fournier, Jorg Kallen, Jean-Marc Schlaeppi
  • Patent number: 5756683
    Abstract: The present invention relates to monoclonal antibodies that are distinguished by a high degree of selectivity and affinity towards herbicides from the group of the sulfonylureas, especially towards sulfonylurea herbicides of formula (A) ##STR1## wherein X is a mono- or di-substituted 6-membered heterocycle having from one to three nitrogen atoms and bonded via carbon, but is preferably mono- or di-substituted s-triazine or pyrimidine; andn is an integer from 0 to 4, preferably the number 1, and that are therefore outstandingly suitable for use in an immunoassay for the rapid and effective detection of the said sulfonylurea herbicides in soil, water or air samples or in plant extracts, and to methods for the production of said monoclonal antibodies. The present invention relates also to hybridoma cell lines that produce said monoclonal antibodies and to immunological detection methods using said monoclonal antibodies, and to test kits that may be used in those detection methods.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: May 26, 1998
    Assignee: Novartis Finance Corporation
    Inventors: Jean-Marc Schlaeppi, Dietmar Huglin
  • Patent number: 5576188
    Abstract: The present invention relates to monoclonal antibodies which are distinguished by high selectivity and affinity for metolachlor and which are therefore outstandingly suitable for use in an immunoassay for the rapid and efficient detection of metolachlor. Another aspect of the present invention relates to hybridoma cell lines which produce said monoclonal antibodies and to immunological methods for detecting metolachlor in samples of soil, water or air using said monoclonal antibodies and to the test kits which can be used within the scope of these detection methods.
    Type: Grant
    Filed: December 20, 1994
    Date of Patent: November 19, 1996
    Assignee: Ciba-Geigy Corporation
    Inventors: Jean-Marc Schlaeppi, Klaus Ramsteiner, Hans Moser
  • Patent number: 5563074
    Abstract: The present invention relates to monoclonal antibodies that are distinguished by a high degree of selectivity and affinity towards triasulfurone and that are therefore outstandingly suitable for use in an immunoassay for the rapid and effective detection of triasulfurone. The present invention relates also to hybridoma cell lines that produce the said monoclonal antibodies and to immunological methods for the detection of triasulfurone in soil, water or air samples using the said monoclonal antibodies and to test kits that may be used in those detection methods.
    Type: Grant
    Filed: July 15, 1994
    Date of Patent: October 8, 1996
    Assignee: Ciba-Geigy Corporation
    Inventors: Jean-Marc Schlaeppi, Klaus Ramsteiner, Willy Meyer
  • Patent number: 5516938
    Abstract: The present invention relates to monoclonal antibodies that are distinguished by a high degree of selectivity and affinity towards herbicides from the group of the sulfonylureas, especially towards sulfonylurea herbicides of formula (A) ##STR1## wherein X is a mono- or di-substituted 6-membered heterocycle having from one to three nitrogen atoms and bonded via carbon, but is preferably mono- or di-substituted s-triazine or pyrimidine; andn is an integer from 0 to 4, preferably the number 1, and that are therefore outstandingly suitable for use in an immunoassay for the rapid and effective detection of the said sulfonylurea herbicides in soil, water or air samples or in plant extracts, and to methods for the production of said monoclonal antibodies.The present invention relates also to hybridoma cell lines that produce said monoclonal antibodies and to immunological detection methods using said monoclonal antibodies, and to test kits that may be used in those detection methods.
    Type: Grant
    Filed: January 6, 1995
    Date of Patent: May 14, 1996
    Assignee: Ciba-Geigy Corporation
    Inventors: Jean-Marc Schlaeppi, Dietmar Huglin
  • Patent number: 5359135
    Abstract: The present invention relates to monoclonal antibodies that are distinguished by a high degree of selectivity and affinity towards triasulfurone and that are therefore outstandingly suitable for use in an immunoassay for the rapid and effective detection of triasulfurone. The present invention relates also to hybridoma cell lines that produce the said monoclonal antibodies and to immunological methods for the detection of triasulfurone in soil, water or air samples using the said monoclonal antibodies and to test kits that may be used in those detection methods.
    Type: Grant
    Filed: November 29, 1993
    Date of Patent: October 25, 1994
    Assignee: Ciba-Geigy Corporation
    Inventors: Jean-Marc Schlaeppi, Klaus Ramsteiner, Willy Meyer
  • Patent number: 5296352
    Abstract: The invention concerns monoclonal antibodies which are directed against the thrombin/hirudin-complex and derivatives thereof, processes for their preparation, hybridoma cell lines secreting said monoclonal antibodies, and processes for the preparation of the hybridoma cell lines. Furthermore, the invention relates to the use of the monoclonal antibodies and/or their derivatives for the determination of the thrombin/hirudin-complex as well as to test kits comprising said monoclonal antibodies and/or their derivatives.
    Type: Grant
    Filed: September 23, 1991
    Date of Patent: March 22, 1994
    Assignee: Ciba-Geigy Corporation
    Inventor: Jean-Marc Schlaeppi
  • Patent number: 5272059
    Abstract: The invention concerns a process for the preparation of hybridoma cells which secrete monoclonal antibodies specific for hirudin, the hybridoma cells themselves, the monoclonal antibodies specific for hirudin secreted by these hybridoma cells, derivatives thereof, and a process for the preparation of said antibodies and derivatives. These monoclonal anti-hirudin antibodies and their derivatives are useful for the determination of hirudin and as an antidote to hirudin. The invention also concerns test kits and pharmaceutical compositions comprising said monoclonal antibodies and/or derivatives.
    Type: Grant
    Filed: July 27, 1992
    Date of Patent: December 21, 1993
    Assignee: Ciba-Geigy Corporation
    Inventors: Jean-Marc Schlaeppi, Dietmar G. Braun